Richardson Peter A, Kansara Sagar, Chen George G, Sabichi Anita, Sikora Andrew G, Parke Robert B, Donovan Donald T, Chiao Elizabeth, Sandulache Vlad C
Houston VA Health Services Research and Development Center Michael E. DeBakey Veterans Affairs Medical Center Houston Texas U.S.A.
ENT Section, Operative Care Line Michael E. DeBakey Veterans Affairs Medical Center Houston Texas U.S.A.
Laryngoscope Investig Otolaryngol. 2018 Aug 9;3(4):275-282. doi: 10.1002/lio2.170. eCollection 2018 Aug.
Veterans with laryngeal and oropharyngeal cancer remain an understudied patient population despite a high incidence of disease and decreased survival compared to the general population. Our objective was to evaluate treatment patterns for laryngeal and oropharyngeal cancer in patients treated at one of the Veterans Health Administration's busiest cancer centers in order to generate some basic benchmarks for treatment delivery in the veteran population.
We reviewed 338 patients treated at the Michael E. DeBakey Veterans Affairs Medical Center between 2000 and 2012.
Oropharyngeal site and advanced age were associated with worse overall and disease-free survival. Treatment periods (mean) were as follows: 1) referral-diagnosis, 26 days; 2) diagnosis-surgery, 29 days; and 3) diagnosis-radiation, 58 days. Adjuvant radiation was initiated within 6 weeks of surgery in 42% of patients and 68% of patients had a total treatment package time ≤100 days. Time from diagnosis to treatment initiation, surgery to adjuvant radiation interval and total treatment package time did not impact survival.
This study establishes basic benchmarks for laryngeal and oropharyngeal cancer treatment delivery in veterans. Additional efforts are warranted to improve consistency and provide treatment in line with NCCN recommendations and literature consensus.
2b.
尽管喉癌和口咽癌在退伍军人中的发病率较高且生存率低于普通人群,但该患者群体仍未得到充分研究。我们的目的是评估在退伍军人健康管理局最繁忙的癌症中心之一接受治疗的喉癌和口咽癌患者的治疗模式,以便为退伍军人人群的治疗提供一些基本基准。
我们回顾了2000年至2012年间在迈克尔·E·德巴基退伍军人事务医疗中心接受治疗的338例患者。
口咽癌发病部位和高龄与较差的总生存率和无病生存率相关。治疗周期(平均)如下:1)转诊至诊断,26天;2)诊断至手术,29天;3)诊断至放疗,58天。42%的患者在手术后6周内开始辅助放疗,68%的患者总治疗时间≤100天。从诊断到开始治疗的时间、手术到辅助放疗的间隔时间和总治疗时间均不影响生存率。
本研究为退伍军人喉癌和口咽癌的治疗提供了基本基准。需要做出更多努力来提高治疗的一致性,并根据美国国立综合癌症网络(NCCN)的建议和文献共识提供治疗。
2b。